Home Hedera Dx

Hedera Dx

In operation
Series A
Liquid Biopsy Product Developer
Basic
Enterprise Profile

Basic Information

Hedera Dx's mission is to make liquid biopsies a reality in global clinical practice to help more cancer patients access better treatment options and achieve better outcomes. Hedera Dx will launch its first solution for biomarker-guided treatment selection in advanced disease.
Hedera Dx
Switzerland
15~50 people
July 01, 2021
--

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing
Technology
Liquid Biopsy
Concept
Tumor Laboratory Diagnosis
Application Scenarios
Medical Devices Medical Device Consumables Early Disease Screening